PRQR · ProQR Therapeutics N.V.
Market Cap
$292.12M
Shares
141.12M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-13 | — | |
| 6-K | 2026-08-13 | 2026-06-30 | |
| 6-K | 2026-06-26 | — | |
| 6-K | 2026-06-25 | — | |
| 6-K | 2026-06-02 | — | |
| 6-K | 2026-05-12 | 2026-03-31 | |
| 6-K | 2026-05-12 | — | |
| 6-K | 2026-05-04 | — | |
| 6-K | 2026-04-30 | — | |
| 6-K | 2026-04-08 | — | |
| 6-K | 2026-04-08 | — | |
| 6-K | 2026-03-25 | — | |
| 6-K | 2026-03-12 | — | |
| 20-F | 2026-03-12 | 2025-12-31 | |
| 6-K | 2026-02-09 | — | |
| 6-K | 2026-01-08 | — | |
| 6-K | 2025-11-06 | 2025-09-30 | |
| 6-K | 2025-11-03 | — | |
| 6-K | 2025-10-20 | — | |
| 6-K | 2025-08-07 | 2025-06-30 | |
| 6-K | 2025-06-26 | — | |
| 6-K | 2025-06-03 | — | |
| 6-K | 2025-05-08 | 2025-03-31 | |
| 6-K | 2025-05-01 | — | |
| 6-K | 2025-04-14 | — | |
| 20-F | 2025-03-13 | 2024-12-31 | |
| 6-K | 2025-03-13 | — | |
| 6-K/A | 2024-12-12 | — | |
| 6-K | 2024-12-11 | — | |
| 6-K | 2024-12-11 | — | |
| 6-K | 2024-12-10 | — | |
| 6-K | 2024-12-05 | — | |
| 6-K | 2024-11-07 | 2024-09-30 | |
| 6-K | 2024-10-25 | — | |
| 6-K | 2024-08-08 | 2024-06-30 | |
| 6-K | 2024-05-22 | — | |
| 6-K | 2024-05-09 | 2024-03-31 | |
| 6-K | 2024-05-08 | — | |
| 6-K | 2024-04-23 | — | |
| 6-K | 2024-04-19 | — | |
| 20-F | 2024-03-13 | 2023-12-31 | |
| 6-K | 2024-03-13 | — | |
| 6-K | 2024-02-15 | — | |
| 6-K | 2024-01-19 | — | |
| 6-K | 2024-01-05 | — | |
| 6-K | 2023-12-08 | — | |
| 6-K | 2023-11-07 | 2023-09-30 | |
| 6-K | 2023-09-27 | — | |
| 6-K | 2023-08-03 | 2023-06-30 | |
| 6-K | 2023-08-01 | — |
Showing 1–50 of 103 filings
Key facts
CIK
1612940
CUSIP
N71542109
13F (30d)
48 filings
48 filers
Visit website
Investor relations